WallStreetZenWallStreetZen

NASDAQ: GRFS
Grifols Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their GRFS stock forecasts and price targets.

Forecast return on equity

Is GRFS forecast to generate an efficient return?

Company
13.99%
Industry
169.9%
Market
76.96%
GRFS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GRFS forecast to generate an efficient return on assets?

Company
3.84%
Industry
20.87%
GRFS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GRFS earnings per share forecast

What is GRFS's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$0.96+300%
Avg 2 year Forecast
$1.33+454.17%
GRFS's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

GRFS revenue forecast

What is GRFS's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$8.1B+7.82%
Avg 2 year Forecast
$8.5B+13.37%
GRFS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GRFS earnings growth forecast

How is GRFS forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
275%
Industry
208.78%
Market
71.14%
GRFS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
GRFS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
GRFS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

GRFS revenue growth forecast

How is GRFS forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
1.08%
Industry
11.05%
Market
59.56%
GRFS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GRFS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GRFS vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
GRFS$7.01N/AN/A
OGN$10.63$19.50+83.44%Buy
AMRN$9.55$7.00-26.70%Strong Sell
SCLX$4.70$630.00+13,304.26%Strong Buy
MIRA$0.87N/AN/A
View Top General Drug Manufacturer Stocks

Grifols Sa Stock Forecast FAQ

What is GRFS's earnings growth forecast for 2025-2026?

(NASDAQ: GRFS) Grifols Sa's forecast annual earnings growth rate of 275% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 208.78%, and it is also forecast to beat the US market's average forecast earnings growth rate of 71.14%.

Grifols Sa's earnings in 2025 is $174,355,555.On average, 2 Wall Street analysts forecast GRFS's earnings for 2025 to be $660,052,712, with the lowest GRFS earnings forecast at $563,795,025, and the highest GRFS earnings forecast at $756,310,399.

In 2026, GRFS is forecast to generate $914,448,028 in earnings, with the lowest earnings forecast at $811,314,791 and the highest earnings forecast at $1,017,581,264.

If you're new to stock investing, here's how to buy Grifols Sa stock.

What is GRFS's revenue growth forecast for 2025-2026?

(NASDAQ: GRFS) Grifols Sa's forecast annual revenue growth rate of 1.08% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 11.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 59.56%.

Grifols Sa's revenue in 2025 is $8,013,757,777.On average, 1 Wall Street analysts forecast GRFS's revenue for 2025 to be $5,569,614,163,294, with the lowest GRFS revenue forecast at $5,569,614,163,294, and the highest GRFS revenue forecast at $5,569,614,163,294.

In 2026, GRFS is forecast to generate $5,856,180,173,399 in revenue, with the lowest revenue forecast at $5,856,180,173,399 and the highest revenue forecast at $5,856,180,173,399.

What is GRFS's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: GRFS) forecast ROA is 3.84%, which is lower than the forecast US Drug Manufacturers - General industry average of 20.87%.

What is GRFS's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: GRFS) Grifols Sa's current Earnings Per Share (EPS) is $0.26. On average, analysts forecast that GRFS's EPS will be $0.96 for 2025, with the lowest EPS forecast at $0.82, and the highest EPS forecast at $1.10. In 2026, GRFS's EPS is forecast to hit $1.33 (min: $1.18, max: $1.48).

What is GRFS's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: GRFS) forecast ROE is 13.99%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.